Authors:
Ruan, QR
Zhang, WJ
Hufnagl, P
Kaun, C
Binder, BR
Wojta, J
Citation: Qr. Ruan et al., Anisodamine counteracts lipopolysaccharide-induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells: Contribution of the NF-kappa B pathway, J VASC RES, 38(1), 2001, pp. 13-19
Authors:
de Maat, MPM
Dooijewaard, G
Meijer, P
Binder, BR
Keber, D
Risberg, B
Kluft, C
Jespersen, J
Citation: Mpm. De Maat et al., Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study, BL COAG FIB, 12(6), 2001, pp. 453-458
Authors:
Redondo, M
Carroll, VA
Mauron, T
Biasiutti, FD
Binder, BR
Lammle, B
Wuillemin, WA
Citation: M. Redondo et al., Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: a low plasma level of plasmin-alpha 2-antiplasmin complex is an independent predictor of coronary re-events, BL COAG FIB, 12(1), 2001, pp. 17-24
Authors:
Vrtala, S
Hirtenlehner, K
Susani, M
Akdis, M
Kussebi, F
Akdis, CA
Blaser, K
Hufnagl, P
Binder, BR
Politou, A
Pastore, A
Vangelista, L
Sperr, WR
Semper, H
Valent, P
Ebner, C
Kraft, D
Valenta, R
Citation: S. Vrtala et al., Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen, Bet v 1, FASEB J, 15(9), 2001, pp. NIL_101-NIL_119
Authors:
Leitinger, N
Huber, J
Rizza, C
Mechtcheriakova, D
Bochkov, V
Koshelnick, Y
Berliner, JA
Binder, BR
Citation: N. Leitinger et al., The isoprostane 8-iso-PGF(2 alpha) stimulates endothelial cells to bind monocytes: differences from thromboxane-mediated endothelial activation, FASEB J, 15(7), 2001, pp. 1254-1256
Authors:
Mechtcheriakova, D
Schabbauer, G
Lucerna, M
Clauss, M
De Martin, R
Binder, BR
Hofer, E
Citation: D. Mechtcheriakova et al., Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells, FASEB J, 15(1), 2001, pp. 230-242
Authors:
Christ, G
Graf, S
Huber-Beckmann, R
Zorn, G
Lang, I
Kneussl, M
Binder, BR
Huber, K
Citation: G. Christ et al., Impairment of the plasmin activation system in primary pulmonary hypertension: Evidence for gender differences, THROMB HAEM, 86(2), 2001, pp. 557-562
Authors:
Plas, E
Carroll, VA
Jilch, R
Simak, R
Mihaly, J
Melchior, S
Thuroff, JW
Binder, BR
Pfluger, H
Citation: E. Plas et al., Variations of components of the plasminogen activation system with the cell cycle in benign prostate tissue and prostate cancer, CYTOMETRY, 46(3), 2001, pp. 184-189
Authors:
Korschineck, I
Ziegler, S
Breuss, J
Lang, I
Lorenz, M
Kaun, C
Ambros, PF
Binder, BR
Citation: I. Korschineck et al., Identification of a novel exon in apolipoprotein E receptor 2 leading to alternatively spliced mRNAs found in cells of the vascular wall but not in neuronal tissue, J BIOL CHEM, 276(16), 2001, pp. 13192-13197
Authors:
Oitzinger, W
Hofer-Warbinek, R
Schmid, JA
Koshelnick, Y
Binder, BR
de Martin, R
Citation: W. Oitzinger et al., Adenovirus-mediated expression of a mutant I kappa B kinase 2 inhibits theresponse of endothelial cells to inflammatory stimuli, BLOOD, 97(6), 2001, pp. 1611-1617
Authors:
Carroll, VA
Mihaly, J
Koshelnick, Y
Hufnagl, P
Binder, BR
Citation: Va. Carroll et al., Overexpression of plasminogen activator inhibitor type-1 in HT-1080 fibrosarcoma cells promotes lung colonisation and in vitro cell adhesion, FIBRINOL PR, 14(4), 2000, pp. 215-220
Authors:
Sperr, WR
Natter, S
Baghestanian, M
Smolen, J
Wolff, K
Binder, BR
Muller, MR
Lechner, K
Valenta, R
Valent, P
Citation: Wr. Sperr et al., Autoantibody reactivity in a case of Schnitzler's syndrome: Evidence for aTh1-like response and detection of IgG2 anti-Fc epsilon RIa antibodies, INT A AL IM, 122(4), 2000, pp. 279-286
Authors:
Uhrin, P
Dewerchin, M
Hilpert, M
Chrenek, P
Schofer, C
Zechmeister-Machhart, M
Kronke, G
Vales, A
Carmeliet, P
Binder, BR
Geiger, M
Citation: P. Uhrin et al., Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility, J CLIN INV, 106(12), 2000, pp. 1531-1539
Authors:
Hofer-Warbinek, R
Schmid, JA
Stehlik, C
Binder, BR
Lipp, J
de Martin, R
Citation: R. Hofer-warbinek et al., Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1, J BIOL CHEM, 275(29), 2000, pp. 22064-22068
Authors:
Schmid, JA
Birbach, A
Hofer-Warbinek, R
Pengg, M
Burner, U
Furtmuller, PG
Binder, BR
de Martin, R
Citation: Ja. Schmid et al., Dynamics of NF kappa B and I kappa B alpha studied with green fluorescent protein (GFP) fusion proteins - Investigation of GFP-p65 binding to DNA by fluorescence resonance energy transfer, J BIOL CHEM, 275(22), 2000, pp. 17035-17042
Citation: Pl. Turecek et al., In vivo inhibition of low density lipoprotein receptor-related protein improves survival of factor VIII in the absence of von Willebrand factor, BLOOD, 95(11), 2000, pp. 3637-3638
Authors:
Mavri, A
Stegnar, M
Krebs, M
Sentocnik, JT
Geiger, M
Binder, BR
Citation: A. Mavri et al., Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women, ART THROM V, 19(6), 1999, pp. 1582-1587
Authors:
Redondo, M
Watzke, HH
Stucki, B
Sulzer, I
Biasiutti, FD
Binder, BR
Furlan, M
Lammle, B
Wuillemin, WA
Citation: M. Redondo et al., Coagulation factors II, V, VII, and X, prothrombin gene 20210G -> A transition, and factor V Leiden in coronary artery disease - High factor V clotting activity is an independent risk factor for myocardial infarction, ART THROM V, 19(4), 1999, pp. 1020-1025
Authors:
Seiberler, S
Bugajska-Schretter, A
Hufnagl, P
Binder, BR
Stockl, J
Spitzauer, S
Valent, P
Valenta, R
Citation: S. Seiberler et al., Characterization of IgE-reactive autoantigens in atopic dermatitis - 1. Subcellular distribution and tissue-specific expression, INT A AL IM, 120(2), 1999, pp. 108-116
Authors:
Seiberler, S
Natter, S
Hufnagl, P
Binder, BR
Valenta, R
Citation: S. Seiberler et al., Characterization of IgE-reactive autoantigens in atopic dermatitis - 2. A pilot study on IgE versus IgG subclass response and seasonal variation of IgE autoreactivity, INT A AL IM, 120(2), 1999, pp. 117-125
Authors:
Vrtala, S
Hirtenlehner, K
Susani, M
Hufnagl, P
Binder, BR
Vangelista, L
Pastore, A
Sperr, WR
Valent, P
Ebner, C
Kraft, D
Valenta, R
Citation: S. Vrtala et al., Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: Candidates for specific immunotherapy, INT A AL IM, 118(2-4), 1999, pp. 218-219